21.11.2014 Views

o_1977r8vv9vk1ts2ms0kd8pksa.pdf

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

628 Subject Index<br />

trisomy 525<br />

trophoblastic infiltration 270<br />

true<br />

± abnormal notch 235<br />

± IUGR 283<br />

± mean instantaneous velocity 445<br />

TTS 320<br />

± absent flow 322<br />

± biphasic venous waveform 322<br />

± fetal Doppler 320<br />

± long-term outcomes 324<br />

± perinatal death 322<br />

± pregnancy 322<br />

± reversed flow 322<br />

± ± in the ductus venosus 322<br />

± ± in the inferior vena cava 322<br />

± serial Doppler 320<br />

± survival 324<br />

± tricuspid insufficiency 322<br />

± umbilical artery velocimetry 320<br />

tubal factor infertility 561<br />

tubo-ovarian abscess<br />

± acute phase 577<br />

± chronic phase 577<br />

± color Doppler ultrasound 577<br />

tumor vascularity 564<br />

twin<br />

± A/B ratio 317<br />

± adverse outcome 325<br />

± gestation 392<br />

± ± prevalence 313<br />

± pregnancy<br />

± ± second-trimester Doppler<br />

study 326<br />

± ± transvaginal uterine artery Doppler<br />

326<br />

± ± umbilical artery Doppler 326<br />

± S/D ratio 317<br />

± transfusion 316<br />

± transfusion syndrome<br />

± ± amniotic fluid differences 319<br />

± ± amniotic fluid volume 319<br />

± ± fetal weight 319<br />

± ± hemoglobin differential 319<br />

± ± individualized growth assessment<br />

319<br />

± ± oligohydramnios 319<br />

± ± Rossavik growth models 319<br />

± ± scoring system 319<br />

± ± standards of birth weight 319<br />

± ± zygosity 319<br />

twin-twin transfusion 203<br />

± abnormal umbilical S/D<br />

ratios 530<br />

± diagnostic criteria 530<br />

± ductus venosus blood flow 531<br />

± hemoglobin difference 530<br />

± increased nuchal fold 531<br />

± monoamniotic twin gestation 530<br />

± monochorionic placentation 530<br />

± vascular communications 530<br />

± weight discordance 530<br />

two-dimensional (2D)<br />

±array 30<br />

±matrixarray<br />

± ± piezoelectric elements 510<br />

Tyndall light 14<br />

type-I diabetes<br />

± aortic peak 334<br />

± E/A ratio 334<br />

± fetal cardiac function 334<br />

± mellitus<br />

± ± decidual microvascular pathology<br />

334<br />

± ± uterine arcuate artery Doppler<br />

334<br />

± pulmonary peak 334<br />

± time-to-peak velocity 334<br />

U<br />

ultrasonographic biometry 317<br />

ultrasound<br />

± B-flow 41<br />

± evaluation of TTS 319<br />

± monitoring of conservative management<br />

586<br />

ultrasound-guided salpingocentesis<br />

586<br />

umbilical<br />

± arterial A/B (S/D) ratio 367<br />

± arterial absent flow 377<br />

± arterial AREDV 383<br />

± arterial Doppler<br />

± ± adverse perinatal outcome 332<br />

± ± umbilical arterial SD ratio 332<br />

± ± vasculopathy 332<br />

± arterial reverse flow 377<br />

± arterial systolic/diastolic (S/D) 366<br />

± artery 372<br />

± ± acute hypoxemia 125<br />

± ± continuous-wave Doppler interrogation<br />

133<br />

± ± Doppler interrogation 133<br />

± ± ductus venosus and liver 125<br />

± ± embolization 540<br />

± ± flow velocity waveform 304<br />

± ± individual resistance 125<br />

± ± innervation 125<br />

± ± Pourcelot index (PI) 353, 354,<br />

372<br />

± ± pulsed Doppler sonography 134<br />

± ± S/D ratio 342, 353, 354, 384<br />

± ± total resistance 125<br />

± ± umbilical veins 125<br />

± ± vascular impedance 540<br />

± ± vasoactive agents 125<br />

± ± velocimetry 324<br />

± artery Doppler 286, 371<br />

± ± acidosis 369<br />

± ± hypoxia 369<br />

± ± longitudinal comparison 355<br />

± ± result 371<br />

± ± velocimetry acidemia 370<br />

± ± velocimetry hypercarbia 370<br />

± circulatory response<br />

± ± acidosis 371<br />

± ± hypercapnia 371<br />

± ± hypoxia 371<br />

± cord 549<br />

± ± compression 192<br />

± ± cord blood 303<br />

± sinus 518<br />

± vein 60, 290, 370, 406, 413, 416<br />

± ± pulsation 539, 543<br />

± ± blood flow 521<br />

± vein diameter<br />

± ± inter-/intra-observer coefficients<br />

of variation 444<br />

± vein flow<br />

± ± clinical vein flow 444<br />

± ± gestational age 444<br />

± ± reproducibility 444<br />

± venous<br />

± ± blood 538<br />

± ± blood flow 322, 539<br />

± ± blood gas 371<br />

± ± blood pH 371<br />

± ± flow, diffusion technique 445<br />

± ± flow, Doppler technique 445<br />

± ± flow, pregnancy 445<br />

± ± pressure 406<br />

± ± pulsation 410<br />

± ± return 121<br />

± ± tracing 549<br />

± ± velocity 63<br />

± volume flow<br />

± ± chronic hypoxia 447<br />

± ± ductal dilatation 447<br />

± ± per kilogram fetal weight 446<br />

umbilical-placental blood flow 117<br />

± brain flow 117<br />

umbilical-placental circulation, regulation<br />

125<br />

unexplained infertility 588<br />

± endometrial perfusion 588<br />

uniform insonation method 40<br />

unilateral<br />

± cystic kidney 221<br />

± notching 302<br />

± salpingectomy 565<br />

univentricular chamber<br />

± Doppler color flow 492<br />

untwisted ovary 564<br />

ureteropelvic junction (UPJ) obstruction<br />

220<br />

uterine<br />

± artery 113, 227, 255, 345, 549,<br />

571<br />

± ± abdominal 262<br />

± ± angle of incidence 233<br />

± ± compliance 232, 266<br />

± ± continuous-wave Doppler 262<br />

± ± diameter 234<br />

± ± Doppler color flow mapping<br />

263<br />

± ± duplex scanning 262<br />

± ± false positive 299<br />

± ± maximum peak systolic velocity<br />

235

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!